Filing Flows › Apyx Medical (APYX) › Q2 2026 › vs Q2 2025
Apyx Medical (APYX) Q2 2026 vs Q2 2025 (year over year)
Apyx Medical's revenue rose $2.5M (+22%) from $11.4M in Q2 2025 to $13.9M in Q2 2026.
Apyx Medical, Q2 2026: revenue $13.9M (+22% year over year), operating margin -13.0%, net loss $3.1M, operating cash flow −$3.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $13.9M | $11.4M | $2.5M | +22% |
| Net loss | $3.1M | $3.7M | −$666K | -18% |
| Costs & expenses | $17.0M | $15.1M | $1.8M | +12% |
| Operating costs | $15.7M | $13.9M | $1.7M | +12% |
| Interest & other, net | $1.1M | $1.1M | $27K | +2% |
| Income tax | $124K | $49K | $75K | +153% |
| Cost of revenue | $5.0M | $4.3M | $724K | +17% |
| Research & development | $793K | $824K | −$31K | -4% |
| SG&A | $5.3M | $4.3M | $1.0M | +24% |
| Other operating costs | $4.6M | $4.6M | $30K | +0.7% |
| Operating cash sources | $4.8M | $1.9M | $2.9M | +153% |
| Depreciation & amortization | $196K | $132K | $64K | +48% |
| Share-based compensation | $1.1M | $520K | $554K | +107% |
| Cash used in operations | $3.5M | $1.2M | $2.3M | +183% |
| Net loss absorbed | $3.1M | $3.7M | −$666K | -18% |
| Working capital & other | $1.7M | −$1.9M | $3.5M | — |
Questions
How much did Apyx Medical's revenue grow year over year in Q2 2026?
Apyx Medical's revenue rose $2.5M (+22%) from $11.4M in Q2 2025 to $13.9M in Q2 2026.